Civil Court (Undecided Case No. 2374/2562 and Decided Case No. 6984/2563). The Court of Appeal’s decision is final.SEC Secretary-General Ruenvadee Suwanmongkol said: “This is a case of unfair treatment

Microsoft Word - MD&A_E Q1_2561_จัดใหม่ Management Discussion and Analysis: MD&A 1. Company Situation Revenue from the waste treatment business for Q1/2018 slightly increased compare to Q1/2017. The

Company and its subsidiary for Quarter 3 of 2019 ending on 30 September 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical

subsidiary for Quarter 1 of 2020 ending on 31 March 2020 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st

principally engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical business which Hemodialysis

of both treatment of industrial waste business division and property development business division is 342.4 million Baht compared with same period of year 2016 amounted 378.6 million Baht, decreased

the investment in the construction of the Central Wastewater Treatment Plant and Collecting System of the Industrial Zone of Mandalay, the Republic of the Union of Myanmar which is deemed to an

Water Sales, and Wastewater Treatment Services. 2 Other Revenue consists of Excessive Charge, Service Fees for Wastewater Management, and Revenue from Solar Rooftop 3 Gross Profit from Operation excludes

Normalized Profit attributable to Owners of the Parent 363.3 1,406.6 1,043.3 287.2 1 Operating Revenue consists of Raw Water Sales, Industrial Water Sales, and Wastewater Treatment Services. 2 Other Incomes

attributable to Owners of the Parent6 394.2 465.5 -15.3% 1 Operating Revenue consists of Raw Water Sales, Industrial Water Sales, and Wastewater Treatment Services. 2 Other Utilities Revenue consists of